Swainsonine inhibits proliferation and collagen synthesis of NIH-3T3 cells by declining miR-21

Swainsonine (SW) is an indolizidine alkaloid first discovered in Swainsona canescens. This study explored the effects of SW on mouse embryo fibroblast NIH-3T3 cell proliferation and Collagen synthesis, as well as potential molecule mechanisms. We discovered that SW exposure lowered the viability and proliferation of NIH-3T3 cells. The Collagen synthesis was reduced after SW exposure, as evidenced by declines of the mRNA and protein levels of Collagen I (CoI I), Collagen III (CoI III) and α-smooth muscle actin (α-SMA) in NIH-3T3 cells, as well as reduction of Collagen concentration in the culture supernatant of NIH-3T3 cells. Mechanically, transforming growth factor β1 (TGF-β1) stimulation elevated the microRNA-21 (miR-21) expression in NIH-3T3 cells. SW reversed the TGF-β1-caused elevation of miR-21. Up-regulation of miR-21 attenuated the inhibitory influences of SW on NIH-3T3 cell viability, proliferation and Collagen synthesis. Silence of miR-21 had converse influence. Besides, SW inactivated PI3K/Akt and NF-κB pathways via declining miR-21. Altogether, SW inhibited the proliferation and Collagen synthesis of fibroblast NIH-3T3 might be through declining miR-21 and then suppressing PI3K/Akt and NF-κB pathways. SW may be an effective therapeutic medicine for scar hyperplasia.